Array comparative genomic hybridization (aCGH) is a molecular cytogenetic technique used to detect copy number variations (CNVs) across the genome, providing a high-resolution assessment of chromosomal imbalances. It is widely used in clinical diagnostics and research to identify genetic abnormalities associated with developmental disorders, cancers, and other genetic diseases.
Disease susceptibility refers to the likelihood of an individual developing a disease based on genetic, environmental, and lifestyle factors. Understanding these factors is crucial for predicting disease risk and developing personalized prevention and treatment strategies.
Genomic microarrays are powerful tools that allow researchers to analyze the expression of thousands of genes simultaneously, providing insights into gene function, regulation, and interactions. They facilitate the comparison of gene expression profiles between different cell types, conditions, or treatments, advancing our understanding of genetic contributions to diseases and aiding in the development of personalized medicine.
Duplications refer to the process or result of creating an exact copy of a data set, document, or genetic sequence, often to preserve information or enhance redundancy. This concept is crucial in various fields, including data management, genetics, and intellectual property, where it can impact both efficiency and legality.
Dosage sensitivity refers to the phenomenon where the number of copies of a gene (gene dosage) affects the phenotype, with deviations from the normal dosage potentially leading to disease. It is crucial in understanding genetic disorders, particularly those involving duplications or deletions of chromosomal regions.
The genetics of epilepsy involves the study of how genetic variations contribute to the susceptibility and manifestation of epileptic disorders. Understanding these genetic factors can lead to improved diagnosis, personalized treatment, and potential prevention strategies for epilepsy.